Psychiatric Genomics Consortium (PGC)

The purpose of the Psychiatric Genomics Consortium (PGC) is to conduct meta-analyses of genome-wide genetic data for psychiatric disease.

The PGC has been committed to full and open sharing of data and results since its inception. This has become the community standard in human genetics, and is mandated by one of our funders, the U.S. National Institutes of Mental Health.

The key advantage of open-source is the speed of progress. The extension to the genetics of psychiatric disorders is clear: the more qualified research groups that can work on the genetics of these important human conditions, the more likely we are to see tangible and verifiable progress. The main goal is to maximize our knowledge and an “open-source” approach is consistent with this aim.